SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC
Clinical trial NCT05732662 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05732662
- Sponsor
- The First People's Hospital of Changzhou
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2025-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.